References
- Albain KS, Crowley JJ, LeBlanc M, et al (1991). Survival determinants in extensive-stage non-small cell lung cancer: the southwest oncology group experience. J Clin Oncol, 9, 1618-26.
- Arinc S, Ece F, Ertugrul M, et al (2009). Prognostic factors of elderly and young advanced stage NSCLC cases. South Med J, 102, 1019-22. https://doi.org/10.1097/SMJ.0b013e3181b66b11
- Berghmans T, Mascaux C, Haller A, et al (2008). EGFR, TTF-1, and Mdm2 expression in stage III non-small cell lung cancer: a positive association. Lung Cancer, 62, 35-44. https://doi.org/10.1016/j.lungcan.2008.02.003
- Berghmans T, Paersmans M, Sculier JP (2011). Prognostic factors in stage III non-small cell lung cancer: a review on contventional, metabolic and new biological variables. Ther Adv Med Oncol, 3, 127-38. https://doi.org/10.1177/1758834011401951
- Betticher DC, Hsuschmitz SF, Totsch M, et al (2006). Swiss group for clinical cancer research (SAKK). Prognostic factors affecting long-term outcomes in patients with resected stage IIIA, pN2 non-small cell lung cancer: 5-year follow-up of a phase II study. Br J Cancer, 94, 1099-106. https://doi.org/10.1038/sj.bjc.6603075
- Dewys WD, Begg C, Lavin PT, et al (1980). Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern cooperative oncology group. Am J Med, 69, 491-7. https://doi.org/10.1016/S0149-2918(05)80001-3
- Espinosa E, Feliu J, Zamora P, et al (1995). Serum albumin and other prognostic factors related to response and survival in patients with advanced non-small cell lung cancer. Lung Cancer, 12, 67-76. https://doi.org/10.1016/0169-5002(95)00407-R
- Fatzinger P, DeMeester TR, Darakjian H, et al (1984). The use of serum albumin for further classification of Stage III nonoat cell lung cancer and its therapeutic implications. Ann Thorac Surg, 37, 115-22. https://doi.org/10.1016/S0003-4975(10)60297-4
- Fearon KCH, Falconer JS, Slater C, et al (1998). Albumin synthesis rates are not decreased in hypoalbuminemic cachectic cancer patients with an ongoing acute phase protein response. Ann Surg, 227, 249-54. https://doi.org/10.1097/00000658-199802000-00015
- Finkelstein DM, Ettinger DS, Ruckdeschel JC (1986). Long-term survivors in metastatic non-small cell lung cancer: an eastern cooperative oncology group study. J Clin Oncol, 4, 702-9.
- Forrest LM, McMillan DC, McArdle CS, et al (2003). Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small cell lung cancer. Br J Cancer, 89, 1028-30. https://doi.org/10.1038/sj.bjc.6601242
- Forrest LM, McMillan DC, McArdle CS, et al (2005). A prospective longitudinal study of performance status, an inflammation-based score (GPS) and survival in patients with inoperable non-small cell lung cancer. Br J Cancer, 92, 1834-6. https://doi.org/10.1038/sj.bjc.6602591
- Gagnon B, Agunlik JS, Gioulbasanis I, et al (2013). Montreal prognostic score. Estimating survival of patients with nonsmall cell lung cancer using clinical biomarkers. Br J Cancer, 109, 2066-71. https://doi.org/10.1038/bjc.2013.515
- Gupta D, Lammersfeld C, Vashi PG, et al (2009). Is serum albumin an independent predictor of survival in ovarian cancer? Clin Ovarian Cancer, 2, 52-6. https://doi.org/10.3816/COC.2009.n.008
- Gupta D, Lis CG (2010). Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature. Nutr J, 9, 69. https://doi.org/10.1186/1475-2891-9-69
- Hoang T, Xu R, Schiller JH, et al (2005). Clinical model to predict in chemo-naive patients with advanced non-small cell lung cancer treated with third-generation chemotherapy regimend based on Eastern cooperative oncology group data. J Clin Oncol, 23, 175-83. https://doi.org/10.1200/JCO.2005.04.177
- Jafri SH, Shi R, Mills G (2013). Advanced lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a retrospective review. BMC Cancer, 13, 158-67. https://doi.org/10.1186/1471-2407-13-158
- Jin Y, Y, Zhao L, Peng F (2013). prognostic impact of serum albumin levels on the recurrence of stage I non-small cell lung cancer. Clinics, 68, 686-93. https://doi.org/10.6061/clinics/2013(05)17
- Kasymjanova G, MacDonald N, Agulnik JS, et al (2010). The predictive value of pre-treatment inflammatory markers in advanced non-small cell lung cancer. Curr Oncol, 14, 52-8.
- Kaya V, Yildirim M, Demirpence O, et al (2013). Prognostic significance of basic laboratıry methods in non-small cell lung cancer. Asian Pac J Cancer Prev, 14, 5473-6. https://doi.org/10.7314/APJCP.2013.14.9.5473
- Ku JH, Kim M, Choi WS, et al (2014). Preoperative serum albumin as a prognostic factor in patients with upper urinary tract urothelial carcinoma. Int Braz J Urol, 40, 753-62. https://doi.org/10.1590/S1677-5538.IBJU.2014.06.06
- Lai SL and Perng RP (1998). Impact of nutritional status on the survival of lung cancer patients. Zhonghua Yi Xue Za Zhi (Taipei), 61, 134-140.
- Leung EY, Scott HR, McMillan DC (2012). Clinical utility of the pretreatment Glasgow prognostic score in patients with advanced inoperable non-small cell lung cancer. J Thorac Oncol, 7, 655-62. https://doi.org/10.1097/JTO.0b013e318244ffe1
- Maestu I, Pastor M, Gomez-Codina J, et al (1997). Pretreatment prognostic factors for survival in small cell lung cancer: a new prognostic index and validation of three known prognostic indices on 341 patients. Ann Oncol, 8, 547-53. https://doi.org/10.1023/A:1008212826956
- Margarson MP, Soni N (1998). Serum albumin: touchstone or totem? Anaesthesia, 53, 789-803. https://doi.org/10.1046/j.1365-2044.1998.00438.x
- Matsunuma R, Tanbo Y, Asai N, et al (2014). Prognostic factors in patients with terminal stage lung cancer. J Palliat Med, 17, 189-94. https://doi.org/10.1089/jpm.2013.0448
- McMillan DC, Watson WS, O'Gorman P, et al (2001). Albumin concentrations are primarily determined by the body cell mass and the systemic inflammatory response in cancer patients with weight loss. Nutr Cancer, 39, 210-3. https://doi.org/10.1207/S15327914nc392_8
- O'Gorman P, McMillan DC, McArdle CS (1998). Impact of weight loss, appetite, and the inflammatory response on quality of life in gastrointestinal cancer patients. Nutr Cancer, 32, 76-80. https://doi.org/10.1080/01635589809514722
- O'Gorman P, McMillan DC, McArdle CS (2000). Factors predicting survival of advanced gastrointestinal cancer patients with weight loss. Nutr Cancer, 37, 36-40. https://doi.org/10.1207/S15327914NC3701_4
- Paesmans M, Sculier JP, Libert P, et al (1995). Prognostic factors for survival in advanced non-small cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. the European lung cancer working party. J Clin Oncol, 13, 1221-30.
- Seculier JP, Chansky K, Crowley JJ, et al (2008). The impact of additional prognostic factors on survival and their relationship with the anatomical extend of disease expressed by the 6th Edition of the TNM Classification of Malignant Tumors and proposal for the 7th Edition. J Thorac Oncol, 3, 457-66. https://doi.org/10.1097/JTO.0b013e31816de2b8
- Siegel R, Ma J, Zou Z, Jemal A (2014). Cancer statistics, 2014. CA Cancer J Clin, 64, 9-29. https://doi.org/10.3322/caac.21208
- Simons JPFHA, Schols AMWJ, Buurman WA, et al (1999). Weight loss and low body cell mass in males with lung cancer: relationship with systemic inflammation, acutephase response, resting energy expenditure, and catabolic and anabolic hormones. Clin Sci, 97, 215-23. https://doi.org/10.1042/cs0970215
- Tanriverdi O, Cokmert S, Oktay E, et al (2014). Prognostic significance of the baseline serum uric acid level in non-small cell lung cancer patients treated with first-line chemotherapy: a study of the Turkish descriptive oncological researches group. Med Oncol, 31, 217. https://doi.org/10.1007/s12032-014-0217-z
- Trape J, Montesinos J, Catot S, et al (2012). A prognostic score based on clinical factors and biomarkers for advanced nonsmall cell lung cancer. Int J Biol Markers, 27, 257-62. https://doi.org/10.5301/JBM.2012.9314
- Ulas A, Paksoy-Turkoz F, Silay K, et al (2014). A laboratory prognostic index model for patients with advanced non-small cell lung cancer. PLoS ONE, 9, 114471. https://doi.org/10.1371/journal.pone.0114471
- von Meyenfeldt M (2005). Cancer-associated malnutrition: an introduction. Eur J Oncol Nurs, 9, S35-8. Win T, Sharples L, Groves AM, et al (2008). Predicting survival in potentially curable lung cancer patients. Lung, 186, 97-102. https://doi.org/10.1007/s00408-007-9067-1
- Zhang P, Xi M, Li QQ, et al (2014). The modified Glasgow Prognostic Score is an independent prognostic factor in patients with inoperable thoracic esophageal squamous cell carcinoma undergoing chemotherapy. J Cancer, 5, 689-95. https://doi.org/10.7150/jca.9569
Cited by
- Glasgow prognostic score predicts prognosis of non-small cell lung cancer: a meta-analysis vol.5, pp.1, 2016, https://doi.org/10.1186/s40064-016-2093-9
- The prognostic significance of preoperative serum albumin in urothelial carcinoma: a systematic review and meta-analysis vol.38, pp.4, 2018, https://doi.org/10.1042/BSR20180214